{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:53:44Z","timestamp":1761947624950,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s12350-010-9229-z","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T17:57:18Z","timestamp":1271959038000},"page":"853-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Lessons from regadenoson and low-level treadmill\/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patients"],"prefix":"10.1016","volume":"17","author":[{"given":"Deborah H.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel D.","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny","family":"Houghtaling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Lieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Brunken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael A.","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-010-9229-z_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0735-1097(94)90424-3","article-title":"Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry","volume":"23","author":"Cerqueira","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mhj.2001.116070","article-title":"Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?","volume":"142","author":"Balan","year":"2001","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-010-9229-z_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nuclcard.2008.02.009","article-title":"Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial","volume":"15","author":"Leaker","year":"2008","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nuclcard.2007.02.016","article-title":"Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans","volume":"14","author":"Lieu","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nuclcard.2008.02.013","article-title":"Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)","volume":"15","author":"Thomas","year":"2008","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcmg.2008.02.003","article-title":"on behalf of the ADVANCE-MPI Trial Investigators. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: Integrated ADVANCE-MPI trial results","volume":"1","author":"Cerqueira","year":"2008","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1007\/s12350-010-9229-z_bib8","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","article-title":"Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging","volume":"46","author":"Hendel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib9","first-page":"2127","article-title":"Operator-less processing of myocardial perfusion SPECT studies","volume":"36","author":"Germano","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-010-9229-z_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0735-1097(95)00218-S","article-title":"Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography","volume":"26","author":"Berman","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib11","first-page":"2138","article-title":"Automatic quantification of ejection fraction from gated myocardial perfusion SPECT","volume":"36","author":"Germano","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-010-9229-z_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12350-008-9001-9","article-title":"The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging","volume":"16","author":"Thomas","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International union of pharmacology XXV nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1007\/s12350-010-9229-z_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9149(97)00256-7","article-title":"Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology","volume":"79","author":"Shryock","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-010-9229-z_bib15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.93.10.1871","article-title":"Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans","volume":"93","author":"Bertolet","year":"1996","journal-title":"Circulation"},{"key":"10.1007\/s12350-010-9229-z_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.105.095323","article-title":"Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats","volume":"316","author":"Dhalla","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-010-9229-z_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1568026033392246","article-title":"Pharmacology and therapeutic applications of A1 adenosine receptor ligands","volume":"3","author":"Dhalla","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1007\/s12350-010-9229-z_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(24)29370-8","article-title":"Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: Inverse relationship between affinity and duration of action of A2A agonists","volume":"298","author":"Gao","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-010-9229-z_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005344-200301000-00017","article-title":"Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: Potential for use in myocardial perfusion imaging","volume":"41","author":"Trochu","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1007\/s12350-010-9229-z_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0735-1097(94)90424-3","article-title":"Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry","volume":"23","author":"Cerqueira","year":"1994","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-010-9229-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-010-9229-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123041405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123041405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-010-9229-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:50:59Z","timestamp":1761025859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123041405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1071358123041405"],"URL":"https:\/\/doi.org\/10.1007\/s12350-010-9229-z","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from regadenoson and low-level treadmill\/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-010-9229-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}